Oxidative stress has been implicated in the selective degeneration of dopaminergic (DAergic) neurons in Parkinson’s disease (PD). In this study, we tested the efficacy of EUK-134, a superoxide dismutase (SOD) and catalase mimetic, on the nitration of tyrosine hydroxylase (TH), a marker of oxidative stress, and neurotoxicity produced by 1-methyl-4-phenylpyridinium (MPP⁺) and 6-hydroxydopamine (6-OHDA) in primary DAergic neuron cultures. Exposure of cultures to 10 μM MPP⁺ reduced dopamine (DA) uptake and the number of tyrosine hydroxylase immunoreactive (THir) neurons to 56 and 52% of control, while exposure to 30 μM 6-OHDA reduced DA uptake and the number of THir neurons to 58 and 59% of control, respectively. Pretreatment of cultures with 0.5 μM EUK-134 completely protected DAergic neurons against MPP⁺- and 6-OHDA-induced neurotoxicity. Exposure of primary neuron cultures to either MPP⁺ or 6-OHDA produced nitration of tyrosine residues in TH. Pretreatment of cultures with 0.5 μM EUK-134 completely prevented MPP⁺- or 6-OHDA-induced nitration of tyrosine residues in TH. Taken together, these results support the idea that reactive oxygen species (ROS) are critically involved in MPP⁺- and 6-OHDA-induced neurotoxicity and suggest a potential therapeutic role for synthetic catalytic scavengers of ROS, such as EUK-134, in the treatment of PD.